Kαλώς ήρθατε στην online έκδοση της Επιθεώρησης Δερματολογίας – Αφροδισιολογίας
Με μεγάλη χαρά σας ενημερώνουμε για την έναρξη λειτουργίας της online έκδοσης του επιστημονικού περιοδικού Επιθεώρηση Δερματολογίας – Αφροδισολογίας. Η ηλεκτρονική μας πλατφόρμα (www.hdvr.gr) έρχεται να συμπληρώσει την έντυπη έκδοση, προσφέροντας στους αναγνώστες και τους συγγραφείς μια σύγχρονη, ευέλικτη και προσβάσιμη εμπειρία.
Τι προσφέρει η online έκδοση της Επιθεώρησης:
• Άμεση πρόσβαση στα άρθρα από οπουδήποτε.
• Εύκολη αναζήτηση και πλοήγηση σε τρέχοντα και παλαιότερα τεύχη.
• Δυνατότητα ηλεκτρονικής υποβολής άρθρων, με παρακολούθηση της διαδικασίας αξιολόγησης σε πραγματικό χρόνο.
• Εύχρηστο περιβάλλον για την online αξιολόγηση των άρθρων από τους κριτές.
Επιπλέον, με στόχο τη διεύρυνση της απήχησής μας στην επιστημονική κοινότητα, εργαζόμαστε στα εξής σημαντικά επόμενα βήματα:
1. Έκδοση του περιοδικού στην αγγλική γλώσσα, με σκοπό την πλήρη αγγλόφωνη κάλυψη και διεθνή πρόσβαση στις δημοσιεύσεις μας.
2. Συμπερίληψη του περιοδικού στο Index Medicus και άλλες μεγάλες επιστημονικές βάσεις δεδομένων, ώστε να αποκτήσει impact factor και να αναγνωριστεί παγκοσμίως ως έγκριτη πηγή επιστημονικής γνώσης.
Η εξέλιξη αυτή δεν είναι μόνο ένα ορόσημο για την Επιθεώρηση, το ιστορικό και κατ’ εξοχήν επιστημονικό περιοδικό της Ελληνικής Δερματολογίας – Αφροδισιολογίας αλλά και μια ευκαιρία για όλους τους συναδέλφους, ειδικευμένους και ειδικευόμενους, να προβάλουν το έργο τους σε ένα ευρύτερο, ελληνικό και διεθνές ακροατήριο.
Σας καλούμε να επισκεφθείτε την πλατφόρμα μας στο www.hdvr.gr και να συμμετάσχετε ενεργά σε αυτή τη νέα εποχή της Επιθεώρησης.
Με εκτίμηση,
Καθηγητής Αλέξανδρος Στρατηγός,
Εκδότης
The Hellenic Dermato-Venereological Review (HDVR), issued in print since 1937, is a property of Andreas Syggros Hospital, in Athens, Greece, funded by the “Andreas and Ifigenia Syggros” Trust. HDVR is a quarterly published Greek Dermatology journal well recognized in our discipline.
HDVR encompasses the current international trends in Dermatology-Venereology, informs on pertinent cutaneous and venereal diseases in scholarly reviews and original research articles, case reports and guidance for the clinical practice, and is a forum for the viewpoints of esteemed colleagues in Greece an internationally. Alongside the journal’s Editorial Board, consisting of experts and researchers with international contributions, we will be striving to meet high publishing standards.
HDVR aims to be a useful resource and provide continuing medical education, easily and freely assessed online for residents and specialist dermatologists in Greece and abroad.
Latest Issue
Volume 37,
Issue 1
Editor’s Choice
Vasileios Paparizos, Varvara Vasalou, Theodosios Alestas, Eleni Paparizou, Electra Nicolaidou, Alexander Stratigos
Abstract: The terms DoxyPEP and DoxyPrEP refer to the administration of a single dose of doxycycline after an unprotected sexual contact (DoxyPEP) or the prophylactic long-term administration of doxycycline to people with multiple unprotected sexual contacts (DoxyPrEP), as a protective measure against bacterial sexually transmitted infections (STIs), mainly syphilis, gonorrhea, and chlamydial infections. Guidelines by several international organisations have been published, discussing its use depending on each case, with several reservations regarding the potential development of antimicrobial resistance, the impact on the microbiome, the potential delay in diagnosis and proper treatment of bacterial STIs, and the potential obstruction of partner notification and surveillance.
Latest Articles
Atopic Dermatitis as a Systemic Disorder: A Review of Non-Allergic Comorbidities
Eleni Paschou, Aikaterini Tsentemeidou, Efstratios Vakirlis, Stamatis Gregoriou, Eleni Sotiriou
Hellenic Dermato-Venereological Review 2026, 37(1): 21-28
ABSTRACT: Atopic dermatitis (AD) is the most common chronic inflammatory skin disease, characterized by relapsing eczema with intense pruritus, which greatly affects quality of life. The pathophysiology is complex and multi-factorial. Environmental factors, genetic predisposition, epidermal barrier disruption and dysregulation of the immune system can interact with various ways to ultimate lead to chronic disease. For decades, the association between AD and other allergic conditions has been recognized. More recently, many studies have shown that numerous non-allergic comorbidities, neuropsychiatric, autoimmune, metabolic, cardiovascular, infectious, and cancers have been associated with atopic dermatitis, suggesting that it may be more of a systemic disorder than previously recognized. We conducted a narrative review to synthesize the current evidence on non-allergic comorbidities associated with AD. A comprehensive literature search was performed using original research articles, systematic reviews (SRs), and meta-analyses that focused on adult and pediatric populations with AD.
Exploring the relationship between DUSP3 expression and senescence-associated proliferative status
Emmanouil Chousakos, Nikolaos Katsoulas, Nikolaos I. Vlachogiannis, Irene Theochari, Nikolaos Kavantzas, Alexandros Stratigos, Andreas C. Lazaris
Hellenic Dermato-Venereological Review 2026, 37(1): 37-47
ABSTRACT: Background and Objectives: Dual specificity phosphatase 3 (DUSP3) regulates key components of the MAPK/ERK signaling pathway and has been implicated in melanocytic oncogenesis. Given the central role of oncogene-induced senescence in restraining melanocytic tumor progression, the relationship between DUSP3 expression and proliferative fitness remains unclear. This study aimed to investigate whether DUSP3 expression correlates with the proliferative status of melanocytic neoplasms. Materials and Methods: A retrospective immunohistochemical analysis was performed on 172 melanocytic lesions, including common nevi, dysplastic nevi, and paired nevus and melanoma components of nevus-associated melanomas. β-galactosidase expression was used to stratify lesions according to proliferative fitness, and a biologically defined β-galactosidase–negative/low subgroup was analyzed separately.
Evaluation of the effectiveness and tolerability of a ceramide and hyaluronic acid-based product in adult patients with dry to very dry atopic skin
Efstratios Vakirlis, Stamatios Gregoriou, Katerina Mpakirtzi, Maria Emmanouela Anagnostaki, Ileana Afroditi Kleidona, Parthena Melitzanidou, Katerina Senteimidou, Maria Gioumidou, Aikaterini Patsatsi, Zoe Apalla, Myrto Trakatelli, Alexander Stratigos, Eleni Sotiriou, Elissavet Lazaridou
Hellenic Dermato-Venereological Review 2026, 37(1): 49-59
ABSTRACT: Background and Objectives: Atopic dermatitis (AD) is characterized by chronic inflammation, skin barrier disruption and persistent dryness. Moisturization is a key component of daily management. The aim of this study was to evaluate the effectiveness, tolerance, and impact on quality of life of a moisturizing cream containing ceramides and hyaluronic acid to dry to very dry atopic skin.
Materials and Methods: 121 adults with AD, and mild to severe skin dryness, participated in the study. An initial clinical assessment was conducted, along with self-assessment of patients’ symptoms and their impact on quality of life. All parameters were re-evaluated after 4 weeks of the product’s use, along with tolerance to the product and overall satisfaction.
Evaluation of the efficacy and tolerance of a 2-MNG and niacinamide containing dermocosmetic product as monotherapy, combination therapy, or maintenance therapy in patients with pigmentary disorders
Efstratios Vakirlis, Christina Kemanetzi, Dimitra Kiritsi, Christina Fotiadou
Hellenic Dermato-Venereological Review 2026, 37(1): 61-73
ABSTRACT: Background and Objectives: Pigmentation disorders represent a common dermatological concern with aesthetic and psychosocial consequences. The aim of this study was to evaluate the effectiveness and tolerability of a dermocosmetic serum containing the novel depigmenting agent 2-mercaptonicotinoyl glycine (2-MNG, Melasyl™) and niacinamide, under real-world conditions.
Materials and Methods: 800 adults with pigmentation disorders participated. A clinical assessment was initially conducted, along with self-assessment of patients’ symptoms and their impact on quality of life. All parameters were re-evaluated after 3 months of use (as monotherapy, in combination with other treatments, or as maintenance therapy). Tolerance and satisfaction were also assessed.
Guidelines for authors
View our latest issue
Follow us!